TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Clinical trial NCT04013802 · RECRUITING
Trial details
- NCT number
- NCT04013802
- Sponsor
- Baylor College of Medicine
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-08
- Primary completion
- 2027-05-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.